paclitaxel : Related Words Words similar in meaning to paclitaxel
- taxane«
- taxol«
- drug«
- chemotherapy«
- nci«
- myers squibb«
- bark«
- taxus brevifolia«
- compound«
- natural product«
- microtubule«
- clinical trial«
- bristol«
- total synthesis«
- abraxane«
- crada«
- pacific yew«
- total synthesis effort«
- practical commercial production«
- paclitaxel drug eluting«
- insulin fibrillation«
- semisynthetic route«
- ovarian damage«
- holton«
- monroe e. wall«
- stent«
- needle«
- chemical understanding«
- mitosis«
- robert a. holton«
- effect«
- cell division«
- semisynthesis«
- european yew«
- supply«
- material«
- exosomes«
- treatment«
- docetaxel«
- quantity«
- taxus baccata«
- phase ii trial«
- al«
- breast cancer«
- ovarian«
- pancreatic«
- tubulin«
- research triangle park«
- phase«
- breast«
- process«
- congressional hearing«
- melanoma«
- ovarian cancer«
- finding«
- apoptosis«
- goodman«
- zilver ptx«
- yew tree plantation sourcing«
- yew population«
- van der waal ’s force«
- usda botanist«
- u.s. national cancer institute screening program«
- toxic solvent delivery method«
- total synthesis activity«
- thermal titration calorimetry«
- tetracyclic 17-carbon«
- taxus sample«
- taxus brevifola«
- taxus bark«
- taxomyces andreanae«
- taxol(r«
- taxane family«
- specific taxus cell line«
- specialist ccnsc subcontractor«
- solvent cremophor el«
- single pacific yew tree«
- short semisynthesis«
- remarkable response rate«
- recurrent narrowing«
- purified taxol«
- pure compound taxol«
- publications—has«
- public screening center«
- proprietary access«
- practical semisynthetic production route«
- potier process«
- phyton biotech«
- phyllosticta citricarpa«
- pestalotiopsis terminaliae«
- pestalotiopsis pauciseta«
- pestalotiopsis breviseta«
- paclitaxel treatment«
- paclitaxel production«
- paclitaxel coating limit«
- paclitaxel c«
- pacific yew bark«
- original isolation method«
- november nci«
- nodulisporium sylviforme«
- nigrospora sp«
- mutant motor protein«
- multiyear efforts—11«
- microtubule integrity«
- metaphase spindle configuration«
- leukaemic mouse«
- jonathan hartwell«
- isolation laboratory«
- insulin:paclitaxel«
- holton submission«
- hauser chemical research«
- gordon cragg«
- gliocladium sp«
- fresh taxus sample«
- femoropopliteal artery placement«
- endophytic fungus penicillium raistrickii«
- ecological controversy«
- drug resistant mouse tumor cell«
- current bark stock«
- crada application«
- coronary artery placement«
- core synthetic route«
- compound taxol«
- common dosing«
- colleague wani«
- chaetomella raphigera«
- cancer monopoly«
- botryodiplodia theobromae pat«
- arthur s. barclay«
- anthracyclic chemotherapy«
- angiotech pharmaceutical inc.«
- american firm bristol«
- alternative delivery agent«
- alternaria taxi«
- abcd ring system«
- cell«
- florida state university«
- patient«
- xenograft study«
- viable starting material«
- type core«
- successful total synthesis«
- substantial scholarly book«
- spindle function«
- simple natural product«
- similar compounds«
- restenosis«
- refractory ovarian cancer«
- production strain«
- polyoxyethylated castor oil«
- phyllosticta tabernaemontanae«
- patient unsuitable«
- normal bowel habit«
- nci researcher«
- monosporus«
- microtubule stabilizer«
- initial sourcing«
- eventual demand«
- cytoskeletal drug«
- animal toxicology study«
- unusual bruising«
- pestalotiopsis versicolor«
- nucleating factor«
- neointima«
- motility assay«
- microtubule polymer«
- microtubule motor protein«
- cnrs campus«
- antiproliferative agent«
- terpenoid pathway«
- spontaneous tendency«
- plant cell fermentation«
- other trademark«
- nonsmall cell lung cancer«
- molecular pharmacologist«
- hazel plant«
- gnrh analog«
- clinical toxicity«
- cancer chemotherapy national service center«
- baccatin iii«
- recent study«
- stage addition«
- peripheral stent«
- multiple sclerosis treatment«
- kuwajima«
- financial scale«
- tubulin subunit«
- susan b. horwitz«
- t. baccata«
- pierre potier«
- mitotic spindle assembly«
- microtubule detachment«
- mansukh c. wani«
- trade«
- severe exhaustion«
- natural product branch«
- mukaiyama«
- mitotic checkpoint«
- heptadecane«
- cremophor el«
- cladosporium cladosporioides«
- active stereoisomer«
- academic research team«
- nice«
- cook medical«
- concentration lower«
- suppression«
- solid tumor cancer«
- phomopsis«
- iii trial«
- future patent«
- colorectal cancer cell«
- alternative supply route«
- tree«
- prolonged activation«
- linear synthesis«
- federal supply«
- cancer community«
- american chemical society meeting«
- right«
- taxotere«
- pacific yew tree«
- normal breakdown«
- danishefsky«
- cellular assay«
- abraxis bioscience«
- lung«
- microtubule assembly«
- fusarium solani«
- drug controller general«
- convergent synthesis«
- synthesis«
- vitro system«
- synthetic strategy«
- nice guidance«
- k. c. nicolaou«
- trademark«
- wall«
- teniposide«
- process yield«
- nci.«
- melanoma patient«
- biological testing«
- isolation«
- therapeutic concentration«
- external institution«
- brittle hair«
- leuprolide«
- larger trial«
- exclusive marketing right«
- facial flushing«
- synthetic chemist«
- positive breast cancer«
- foot syndrome«
- endophytic fungi«
- synthetic origin«
- metarhizium anisopliae«
- cladosporium«
- remyelination«
- vitro assay«
- variable yield«
- taxanes«
- future availability«
- wender«
- structure«
- fermentation tank«
- nicolaou«
- combination chemotherapy«
- microtubule dynamic«
- synthetic approach«
- forest north«
- company report«
- adjuvant treatment«
- endophytes«
- company«
- testing«
- screening program«
- publication«
- current stock«
- crude extract«
- research triangle institute«
- neil edward«
- mucor«
- u.s. national cancer institute«
- stereocenters«
- advanced breast cancer«
- mouse study«
- improved process«
- biocon«
- molar ratio«
- alternaria«
- chromosome segregation«
- excipient«
- pure material«
- adjuvant chemotherapy«
- biosynthesis«
- taxus«
- podocarpus«
- female infertility«
- informal arrangement«
- curative treatment«
- synthetic method«
- anticancer activity«
- medical testing«
- drug application«
- coincident«
- cyclosporine«
- metastatic disease«
- boston scientific«
- centrosome«
- unknown mechanism«
- wani«
- e.coli«
- packwood«
- ecological concern«
- aqueous medium«
- contradictory evidence«
- colchicine«
- shell«
- mechanism«
- pound«
- sustainable source«
- alternative formulation«
- discovery process«
- cooperative research«
- hatch act«
- activity relationship«
- methyl ester«
- commercial partner«
- generic form«
- public report«
- general accounting office«
- vivo study«
- aspergillus«
- waxman«
- injection site«
- cost«
- development agreement«
- commercial route«
- kaposi«
- % yield«
- month trip«
- fractionation«
- dexamethasone«
- extensive effort«
- cell lung cancer«
- castor oil«
- hand«
- hazardous chemical«
- Taxol«
- 10-deacetylbaccatin iii«
